HomeRGT • ASX
add
Argent BioPharma Ltd
Previous close
$0.23
Day range
$0.25 - $0.25
Year range
$0.15 - $0.73
Market cap
13.57M AUD
Avg Volume
19.17K
P/E ratio
-
Dividend yield
-
Primary exchange
ASX
Market news
Financials
Income Statement
Revenue
Net income
(AUD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | 145.78K | -59.78% |
Operating expense | 4.81M | 29.84% |
Net income | -5.23M | -5.16% |
Net profit margin | -3.59K | -161.47% |
Earnings per share | — | — |
EBITDA | -4.73M | -36.93% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(AUD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 702.87K | 193.08% |
Total assets | 10.79M | 8.05% |
Total liabilities | 16.61M | -7.79% |
Total equity | -5.82M | — |
Shares outstanding | 48.41M | — |
Price to book | -2.09 | — |
Return on assets | -115.73% | — |
Return on capital | -320.16% | — |
Cash Flow
Net change in cash
(AUD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -5.23M | -5.16% |
Cash from operations | -3.38M | -29.16% |
Cash from investing | -61.64K | -270.39% |
Cash from financing | 553.30K | -74.12% |
Net change in cash | -2.89M | -546.56% |
Free cash flow | -1.28M | -19.79% |
About
CEO
Founded
2005
Website